Show
Sort by
-
Potential new autoimmune target in inclusion body myositis
-
Low gene copy numbers of complement C4 and complement C4A deficiency are strong and highly significant genetic risk factors for idiopathic inflammatory myopathy and its major subgroups
(2023) CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. In Clinical and Experimental Rheumatology 41(2). p.416-416 -
Upadacitinib in patients with psoriatic arthritis and inadequate response to biologics : 3-year results from the open-label extension of the randomised controlled phase 3 SELECT-PsA 2 study
-
- Journal Article
- A1
- open access
Cardiovascular comorbidities in psoriatic arthritis : epidemiology and risk factors in two different European populations
-
ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products
-
Atypical variants in COL1A1 and COL3A1 associated with classical and vascular Ehlers-Danlos syndrome overlap phenotypes : expanding the clinical phenotype based on additional case reports
-
Selection of study endpoints and patients for clinical trials in primary Sjögren's syndrome
-
The value of separate detection of anti-Ro52, anti-Ro60 and anti-SSB/La reactivities in relation to diagnosis and phenotypes in primary Sjögren's syndrome
-
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies
-
Off-label use of mycophenolate mofetil in the treatment of rare and complex rheumatic connective tissue diseases